最新刊期

    35 2 2024
    • WANG Xiaolan,PAN Jie,DAI Jing,GE Yi,CHEN Geng,SHI Aiming
      Vol. 35, Issue 2, Pages: 129-133(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.01
      摘要:OBJECTIVETo provide reference for improving the work efficiency of staff and promoting the discipline construction of pharmacy department.METHODSBy analyzing the current situation of performance management in the pharmacy department of our hospital, the key successful factors were sorted out, strategic decoding was carried out and key performance indicators were extracted. The quarterly and annual performance appraisal forms were formulated for the departments of pharmacy warehouse, outpatient pharmacy, ward pharmacy, clinical pharmacy department, prescription examination center, laboratory and other departments; the performance management information platform was built. The work efficiency and output of each department were compared half a year before and after the implementation of the performance management plan.RESULTSAfter the implementation of the program, the average queuing time for drug collection in the outpatient department was shortened from 5 minutes to 3 minutes, the average number of dispensing infusion bags per hour in the pharmacy intravenous admixture services increased from 50 bags to 60 bags, and antibacterial use density of the hospital decreased from 42.7 DDD(defined daily doses) to 40.2 DDD. The number of academic papers published had increased from 8 to 10, and the satisfaction of clinical departments with ward pharmacies increased from 85% to 95%.CONCLUSIONSThe performance management system has been successfully established in pharmacy department of our hospital, which can improve the enthusiasm of pharmacists, reflect the value of pharmaceutical care, and promote the discipline construction of pharmacy.  
      关键词:pharmacy department;performance appraisal;key performance indicators   
      151
      |
      42
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374622 false
      发布时间:2024-01-24
    • YANG Lijuan,WAN Mingyuan,ZHANG Wei,ZHANG Yuqing,LU Jin,ZHEN Jiancun,SHEN Qunhong
      Vol. 35, Issue 2, Pages: 134-139(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.02
      摘要:OBJECTIVETo investigate the current situation of pharmaceutical clinic service in medical institutions in China and provide experience and suggestions for promoting the development of pharmaceutical clinics.METHODSQuestionnaire survey was used to investigate the development of pharmaceutical clinics in medical institutions of 31 provinces (autonomous regions and municipalities directly under the central government) in March to April 2023, and the descriptive analysis was conducted. The regression analysis was carried out for the influential factors of pharmaceutical clinic service.RESULTSA total of 1 368 questionnaires were distributed in this survey and 1 304 valid questionnaires were collected with the effective response rate of 95.32%. A total of 463 medical institutions carried out pharmaceutical clinic service, the rate of which was 35.51% (463/1 304); the rates of pharmaceutical clinics in tertiary, secondary, primary and other medical institutions were 52.80%, 17.18% and 5.88%, respectively. The frequency of opening pharmaceutical clinics was 3.17 days per week on average, with an average of 5.99 visiting pharmacists in each medical institution. Among the visiting pharmacists, clinical pharmacists accounted for the vast majority (88.68%, 2 459/2 773). There were various categories of pharmaceutical clinics, including joint clinics and pharmacist-independent clinics; among pharmacist-independent clinics, pharmaceutical specialty/specialty disease clinics were the main ones, accounting for 89.72% of the total number of pharmaceutical clinics. The value of pharmacists in pharmaceutical clinics was manifested in various forms, among which the proportion of medical institutions charging pharmaceutical clinics was 10.80%. The main experiences in developing pharmaceutical clinics were to attach importance to discipline construction and personnel training. The main difficulties in developing pharmaceutical clinics were low compensation levels and a shortage of talent. The number of clinical pharmacists, the number of visiting pharmacists in pharmaceutical clinics and additional compensation were positively correlated with the amount of pharmaceutical clinic services(P<0.05).CONCLUSIONSIn recent years, pharmaceutical clinics have made significant progress; in the future, it is still necessary to further strengthen discipline construction and talent cultivation, pay attention to the value embodiment of pharmacists, to promote the healthy development of pharmaceutical clinics.  
      关键词:current situation;questionnaire survey;value embodiment   
      66
      |
      20
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374862 false
      发布时间:2024-01-24
    • WANG Yiran,LIU Zhongyong
      Vol. 35, Issue 2, Pages: 140-144(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.03
      摘要:OBJECTIVETo analyze the chemical components and components migrating to the blood of Jianpi huazhuo tiaozhi granules (JHTG).METHODSSD rats were divided into a control group and a medication group, with 6 rats in each group. The medication group was given JHTG 3 mL. Sixty minutes after medication, the serum samples of the 2 groups were collected, and the chemical components and components migrating to the blood of JHTG were separated by ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and mass spectrometry data were collected. Combined with the overall scheme of UNIFI natural products, based on the 6400 natural product theory mass spectrometry database, the structure was analyzed and confirmed by literature review and reference substance comparison. RESULTS &CONCLUSIONSA total of 130 components were identified from JHTG, including 3 in Codonopsis Radix, 13 in Nelumbinis Folium, 15 in Poria, 5 in Atractylodis Macrocephalae Rhizoma, 9 in Citri Reticulatae Pericarpium, 1 in Coicis Semen, 19 in Alisma Rhizoma, 24 in Salviae Miltiorrhizae Radix et Rhizoma, 7 in Hordei Fructus Germinatus, 24 in Crataegi Fructus, 2 in Amomi Fructus, and 3 in Aucklandiae Radix. In addition, quercetin and quercetin-3-O-β-D-glucopyranoside, kaempferol and citric acid may originate from Nelumbinis Folium or Crataegi Fructus, while oleanolic acid may originate from Poria or Crataegi Fructus. By comparing the reference substances, 8 components were finally determined (pachymic acid, atractylenolide Ⅱ, alisol A, alisol B, alantolactone, bornyl acetate, salvianolic acid A, salvianolic acid C). A total of 72 prototype components such as quercetin and kaempferol were identified, mainly including flavonoids, terpenoids, lignans and phenolic acids. A total of 11 metabolites such as dehydroanonaine and 16-O-acetylpachymic acid were identified, mainly terpenoids. Metabolic pathways include phase Ⅰ metabolic reactions such as dehydrogenation and dehydroxylation, and phase Ⅱ metabolic reactions such as methylation and acetylation.  
      关键词:chemical components;components migrating to the blood;UPLC- MS/MS   
      27
      |
      1
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374625 false
      发布时间:2024-01-24
    • XIONG Tingwang,ZHANG Jue,SUN Chengxin,YIN Caixia,CHEN Xi,CHEN Faju
      Vol. 35, Issue 2, Pages: 145-149(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.04
      摘要:OBJECTIVETo explore the antidepressant effect and potential mechanism of icariside Ⅱ (ICSⅡ) based on the GABAergic nervous system.METHODSThe male Kunming mice were randomly divided into a control group (group C, 10 mice) and a modeling group (50 mice). The depression model was induced by chronic unpredictable mild stress (CUMS) method in the modeling group. After 21 days of stimulation, the rats of modeling group were randomly divided into depression model group (NS group), positive control group [ECS group, oxalate escitalopram 15 mg/(kg·d)] and ICSⅡ low-dose, medium-dose and high-dose groups [ICSⅡ-L group, ICSⅡ-M group, ICSⅡ-H group; ICSⅡ 10, 20, 30 mg/(kg·d)], with 10 mice in each group. Administration groups were given relevant medicine intragastrically, once a day, for 14 consecutive days. The sugar water preference rate, total exercise distance, immobility time in tail suspension and forced swimming experiments were detected in each group. The morphology of neurons and Nissl bodies in the hippocampal CA3 region were observed; the contents of γ-aminobutyric acid (GABA) and glutamic acid (Glu), GABA/Glu ratio, and the expressions of GABAergic nervous system-related proteins (GABA A receptor α1, GABA B receptor 1, vesicular GABA transporter, glutamate decarboxylase 67, GABA membranal transporter 3) were detected in hippocampus.RESULTSCompared with group C, the sugar water preference rate and the total exercise distance significantly reduced in NS group, while the values of immobility time in the tail suspension test and forced swimming test were significantly prolonged (P<0.05). The morphology of neurons in the CA3 area of the hippocampus was irregular and the Nissl bodies were reduced, with a significant decrease in the number of structurally intact neurons (P<0.05); the content of Glu was significantly increased, while the content of GABA, GABA/Glu ratio, and the expressions of GABAergic nervous system-related proteins were significantly decreased (P<0.05). Compared with NS group, depression behavior in each administration group was improved, and the above indexes were mostly reversed (P<0.05).CONCLUSIONSICSⅡ can improve depression behavior of depression model mice. The mechanisms may be associated with regulating the balance of GABA and Glu, increasing the synthesis, transport and release of GABA, and regulating the expressions of GABA-related receptors, so as to improve GABAergic nervous system.  
      关键词:depression;chronic unpredictable mild stress;GABAergic nervous system   
      12
      |
      2
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374748 false
      发布时间:2024-01-24
    • ZHU Tianmi,CHEN Shuhe,YAN Jingsong,WANG Xingui,DUAN Yuqing,YANG Xiaoyi
      Vol. 35, Issue 2, Pages: 150-154(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.05
      摘要:OBJECTIVETo establish the characteristic chromatogram of Chaenomeles sinensis, determine the contents of rutin, hyperin and quercitrin, and to identify C. sinensis and C. speciosa.METHODSHPLC method was performed on Agilent 5 TC-C18 column, with acetonitrile-0.2% formic acid solution as the mobile phase for gradient elution, at the flow rate of 1.0 mL/min. The column temperature was 30 ℃. The detection wavelength was 330 nm in characteristic chromatogram and 350 nm in content determination. The characteristic chromatogram of C. sinensis was established and similarity was evaluated by the Similarity Evaluation System for Chromatographic Fingerprint of TCM (2012 edition). Hierarchical cluster analysis of 15 batches of C. sinensis (S1-S15) was performed by using SPSS 23.0 software. The contents of 3 flavones in 15 batches of C. sinensis and 7 batches of C. speciosa (S16-S22) were determined, while their characteristic chromatograms were compared.RESULTSThe similarities of the characteristic chromatogram for 15 batches of C. sinensis ranged from 0.783 to 0.969, and 11 characteristic peaks were confirmed. Four constituents were identified as chlorogenic acid, rutin, hyperin and quercitrin. The medicinal materials in 15 batches of C. sinensis could be divided into 2 categories: S5-S8 were one category, and the others belonged to one category. The characteristic chromatogram of C. sinensis was obviously different from C. speciosa. The contents of rutin, hyperin and quercitrin in 15 batches of C. sinensis were 48.99-294.45, 3.49-102.55, 31.98-149.49 μg/g, respectively. The content of rutin in C. speciosa was lower than that in C. sinensis. None of hyperin (except for S20) and quercitrin were detected in C. speciosa.CONCLUSIONSThe characteristic chromatogram and the method for content determination of 3 flavones in C. sinensis are established successfully and can be used for the quality control of C. sinensis and its identification from C. speciosa.  
      关键词:flavones;characteristic chromatogram;HPLC   
      17
      |
      3
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374986 false
      发布时间:2024-01-24
    • DU Weina,GAO Shuqiang,JU Rong,XI Yufeng
      Vol. 35, Issue 2, Pages: 155-159(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.06
      摘要:OBJECTIVETo investigate the improvement effects of azithromycin on bronchopulmonary dysplasia (BPD) in neonatal rats based on hypoxia-inducible factor-1α(HIF-1α)/HIF-2α/vascular endothelial growth factor (VEGF) pathway.METHODSSixty newborn SD rats were randomly divided into negative control group (NC), BPD group, azithromycin group and budesonide group (positive control), with 15 rats in each group. Rats in NC group were given normal breathing air, while rats in other three groups were exposed to high-concentration oxygen for 14 days to establish BPD rat models. After successful modeling, rats in azithromycin group were intraperitoneally injected with azithromycin 200 mg/kg, and rats in budesonide group were atomized with budesonide 1.5 mg/kg once a day for 14 consecutive days, while rats in BPD group and NC group were not treated. Pathological changes of lung tissue, radial alveolar count and mean alveolar intercept of rats were observed in each group. The white blood cell count in bronchoalveolar lavage fluid (BALF) and the levels of tumor necrosis factor-α (TNF-α), interleukin-6(IL-6), IL-1β, superoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) were detected; mRNA and protein expressions of VEGF, HIF-1α, HIF-2α were also detected.RESULTSCompared with NC group, the lung tissue in BPD group was obviously damaged; the white blood cell count, average alveolar intercept and the levels of TNF-α, IL-6, IL-1β and MDA were significantly increased; the radial alveolar count, SOD and CAT levels, the relative expressions of VEGF, HIF-1α, HIF-2α mRNA and protein were significantly decreased (P<0.05). Compared with BPD group, the changes of the above indexes in azithromycin group and budesonide group were significantly reversed (P<0.05).CONCLUSIONSAzithromycin can obviously improve the symptoms of BPD in rats, reduce inflammation and oxidative stress, and exert lung protection, the mechanism of which may be realized by activating HIF-1α/HIF-2α/VEGF pathway.  
      关键词:bronchopulmonary dysplasia;oxidative stress;immune regulation;hypoxia-inducible factor;vascular endothelial growth factor   
      9
      |
      1
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375030 false
      发布时间:2024-01-24
    • HUANG Mengqin,WANG Xuesong,GAN Yuhan,LU Shiqin,DENG Qiqi,ZHU Qing,GUO Jiao
      Vol. 35, Issue 2, Pages: 160-165(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.07
      摘要:OBJECTIVETo investigate the improvement effects of Runchang granules on the constipation in mice and its potential mechanism.METHODSThe mice were randomly divided into normal control group, model group, Runchang granules low-dose and high-dose groups (5, 10 g/kg), mosapride group (0.003 g/kg, positive control), with 6 mice in each group. The latter 4 groups were given loperamide intragastrically (0.004 g/kg), twice a day, for 3 consecutive days. Normal control group and model group were given purified water intragastrically, and administration groups were given relevant medicine intragastrically for 7 consecutive days. After the last medication, fecal moisture content and intestinal motility of mice were determined, while the structures of colon and ileum, and the secretion of colonic mucus were observed. Protein expressions of tyrosine kinase receptor (c-kit), mucin 2 (MUC2) and stem cell factor (SCF) were determined in colon; meanwhile, the mRNA expression levels of inflammatory factors [tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, inducible nitric oxide synthase (iNOS)] as well as factors related to promoting intestinal motility [neuronal nitric oxide synthase (nNOS), smooth muscle myosin light chain kinase (smMLCK), 5-hydroxytryptamine 4 receptor (5-HT4R), MUC2, SCF, c-kit] were determined.RESULTSCompared with model group, the fecal water content, intestinal propulsion rate, protein expression of c-kit in colon, relative expressions of MUC2 and SCF protein, and mRNA expressions of factors related to promoting intestinal motility (except for nNOS and SCF in Runchang granules low-dose group) were all increased significantly in Runchang granules low-dose and high-dose groups, and mosapride group (P<0.05 or P<0.01). mRNA expression levels of inflammatory factors were decreased significantly(P<0.05 or P<0.01). Both colon and ileum injuries improved, and the secretion of colon mucus was increased significantly in Runchang granules high-dose group (P<0.01).CONCLUSIONSRunchang granules have laxative effect and can improve constipation in mice, and its mechanism may be related to the promotion of the secretion of colon mucus and MUC2 expression, and the activation of SCF/c-kit signaling pathway.  
      关键词:constipation;mucin 2;stem cell factor/c-kit signaling pathway   
      10
      |
      4
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375032 false
      发布时间:2024-01-24
    • LIU Yuhua,LIU Lian,WANG Jiuchong,HUANG Dan,ZHOU Sufang,XIAO Huanzhi,AN Zhenxiang
      Vol. 35, Issue 2, Pages: 166-171(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.08
      摘要:OBJECTIVETo investigate the improvement effects of glycyrrhizin (GL) on Helicobacter pylori (HP)-associated gastritis in rats and its mechanism.METHODSHP-associated gastritis rat model was induced by inoculating with 1×109 cfu/mL HP. The model rats were randomly divided into model group, positive control group (HP standard quadruple group), GL low-dose, medium-dose and high-dose groups (5, 20, 50 mg/kg), with 12 rats in each group. Another 12 healthy rats were selected as normal control group. Except the normal control group and model group were given constant volume of normal saline intragastrically, the other groups were given corresponding drugs intragastrically, once a day, for 30 consecutive days. After administration, rats received 13C urea breath test, and delta-over-baseline (DOB) was recorded; the pathological and cellular morphological changes of gastric mucosa in rats were observed, and pathological scoring was performed; the levels of interleukin-8 (IL-8), IL-1β, tumor necrosis factor-α (TNF-α), reactive oxygen species (ROS) and malondialdehyde (MDA) were detected in gastric mucosa of rats; mRNA expressions of high mobility group box-1 protein (HMGB1) and nuclear factor-κ-B (NF-κB), relative expressions of nitric oxide synthases (iNOS) and HMGB1, the phosphorylation level of NF-κB p65 were also detected in rats.RESULTSCompared with normal control group, the DOB value, histopathological score of gastric mucosa, the levels of IL-8, IL-1β, TNF-α, ROS and MDA, relative expressions of HMGB1 and NF-κB mRNA, relative expressions of iNOS and HMGB1 protein and the phosphorylation level of NF-κB p65 were all increased significantly in model group (P<0.05); the epithelial cells of gastric mucosa in rats were incomplete in structure and decreased in the number, with an increase in cell fragments and vacuoles, and significant cell pyknosis. Compared with model group, the changes of the above indexes in GL groups and positive control group were significantly reversed (P<0.05); the changes in the above indicators in the GL high-dose group were more significant than GL low-dose and medium-dose groups (P<0.05); the pathological changes of gastric mucosal cells in rats had all improved.CONCLUSIONSGL may inhibit inflammation and oxidative stress by inhibiting the activation of HMGB1/NF-κB pathway, thus relieving HP-induced gastric mucosal injury.  
      关键词:high mobility group box 1 protein;nuclear transcription factor-κB;Helicobacter pylori-associated gastritis;gastric mucosal injury   
      9
      |
      2
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374919 false
      发布时间:2024-01-24
    • LIANG Jie,ZHENG Piaoxue,CHEN Huihua,HUANG Chunyan,LIANG Yanli,LU Chunlian,XIE Jingjing,MA Yuming,PENG Jiawen,ZHAO Lichun,CHEN Rilan
      Vol. 35, Issue 2, Pages: 172-178(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.09
      摘要:OBJECTIVETo analyze the metabolites of Zhideke granules and speculate its metabolic pathway in rats in vivo.METHODSMale SD rats were randomly divided into blank group and administration group (Zhideke granules, 9.45 g/kg); they were given ultrapure water or relevant medicine, twice a day, every 6-8 h, for 3 consecutive days. Serum, urine and feces samples of rats were collected, and their metabolites were identified by UPLC-Q-Exactive-MS technique after intragastric administration of Zhideke granules; their metabolic pathways were speculated.RESULTSAfter intragastric administration of Zhideke granules, 16 prototype components (i.g. irisflorentin, baicalin, chlorogenic acid) and 11 metabolites (i.g. hydration products of kaempferol or luteolin, methylation products of chlorogenic acid, and hydroxylation products of baicalin) were identified in serum, urine and feces of rats. Among them, 8 prototype components and 4 metabolites were identified in serum samples; 10 prototype components and 7 metabolites were identified in urine samples; 8 prototype components and 5 metabolites were identified in the fecal samples.CONCLUSIONSThe metabolites of Zhideke granules in rats mainly include baicalin, irisflorentin, chlorogenic acid, and the main metabolic pathways included methylation, hydroxylation, glucuronidation.  
      关键词:UPLC-Q-Exactive-MS;metabolites;metabolic pathway;rat   
      10
      |
      1
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375182 false
      发布时间:2024-01-24
    • CHEN Changgui,YI Chunfeng,YU Zhihua,WANG Dong,LI Liwei,HE Liqun
      Vol. 35, Issue 2, Pages: 179-185(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.10
      摘要:OBJECTIVETo investigate the effects of the peroxisome proliferator-activated receptors δ (PPARδ) agonist GW501516 on the injury of pulmonary artery endothelial cells (PAECs) induced by hypoxia and its mechanism.METHODSThe cytotoxic effects of GW501516 were observed by detecting the relative survival rate of PAECs; the protein expression of PPARδ was determined by Western blot assay. The cellular model of PAECs injury was established under hypoxic conditions; using antioxidant N-acetylcysteine (NAC) as positive control, the effects of GW501516 on cell injury and reactive oxygen species (ROS) production were investigated by detecting cell apoptotic rate, cell viability, lactate dehydrogenase (LDH) activity and ROS levels. Using nuclear factor erythroid 2-related factor 2(Nrf2) activator dimethyl fumarate (DMF) as positive control, PAECs were incubated with GW501516 and/or Nrf2 inhibitor ML385 under hypoxic conditions; the mechanism of GW501516 on PAECs injury induced by hypoxia was investigated by detecting cell injury (cell apoptosis, cell viability, LDH activity), the levels of superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), malondialdehyde (MDA) and ROS, the expressions of Nrf2, heme oxygenase-1 (HO-1) and cleaved-caspase-3 (C-caspase-3) protein.RESULTSThe results demonstrated that hypoxia inhibited the protein expression of PPARδ (P<0.05), while GW501516 promoted the protein expression of PPARδ in hypoxia-exposed PAECs without obvious cytotoxic effects. GW501516 inhibited the apoptosis of PAECs, improved cell viability, and reduced LDH activity and ROS levels. GW501516 could up-regulate the protein expression of HO-1 in PAECs and the levels of SOD, GPx and CAT, while down-regulated the levels of MDA and ROS by activating the Nrf2 pathway (P<0.05); but Nrf2 inhibitor ML385 could reverse the above effects of GW501516 (P<0.05). GW501516 exerted similar effects to Nrf2 activator DMF in down-regulating the expression of C-caspase-3 and inhibiting the injury of PAECs under conditions of hypoxia (P<0.05). Moreover, Nrf2 inhibitor ML385 reversed the inhibition effects of GW501516 on PAECs injury (P<0.05).CONCLUSIONSGW501516 can relieve the hypoxia-induced injury of PAECs via the inhibition of oxidative stress, the mechanism of which may be associated with activating Nrf2.  
      关键词:hypoxia;pulmonary artery endothelial cells;oxidative stress;injury;nuclear factor erythroid 2-related factor 2   
      7
      |
      1
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374898 false
      发布时间:2024-01-24
    • CHEN Jing,YANG Xiaoyi,CHEN Jing,SHAN Xin,WANG Jie,XU Huiqin,LYU Zhiyang
      Vol. 35, Issue 2, Pages: 186-191(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.11
      摘要:OBJECTIVETo investigate the inhibitory effects of Ginkgo biloba extract (GBE) on renal inflammation in diabetic nephropathy (DN) model mice, and its potential mechanism.METHODSKK/Ay mice were fed with high fat and high sugar to induce DN model. They were divided into model group, positive control group [metformin 200 mg/(kg·d)], GBE low-dose and high-dose groups [100, 200 mg/(kg·d)], with 6 mice in each group. Six C57BL/6J mice were fed with a regular diet as the control group. Administration groups were given relevant liquid intragastrically, control group and model group were given constant volume of normal saline intragastrically, once a day, for 8 consecutive weeks. The body weight, fasting blood glucose, 24-hour food intake, 24-hour urine output, monocyte chemoattractant protein-1 (MCP-1), interleukin-12 (IL-12), IL-10, advanced glycation end products (AGEs), blood urea nitrogen (BUN) and serum creatinine (Scr) of mice were measured, and the ratio of bilateral kidneys to body weight was also calculated. The pathological injury and fibrotic changes of the renal cortex were observed, and the expressions of macrophage polarization marker proteins [type M1: inducible nitric oxide synthase (iNOS); type M2: arginase-1 (Arg-1)] and AGEs-the receptor of advanced glycation end products (RAGE)/Ras homolog gene family member A (RhoA)/Rho-associated coiled-coil forming protein kinase (ROCK) signaling pathway-related proteins were determined in renal cortex.RESULTSCompared with the model group, the symptoms such as renal cortical hyperplasia, vacuoles, infiltration of inflammatory cells, and renal cortical fibrosis had been improved in GBE low-dose and high-dose groups; body weight, serum level of IL-10, the expression of Arg-1 in the renal cortex were significantly higher than model group (P<0.01); fasting blood glucose, 24-hour food intake, 24-hour urine output, serum levels of MCP-1, IL-12, BUN, Scr and AGEs, the ratio of bilateral kidneys to body weight, renal injury score, the proportion of renal interstitial fibrosis, the protein expressions of iNOS, RAGE, RhoA and ROCK1 (except for GBE low-dose group) in renal cortex were significantly lower than model group (P<0.01).CONCLUSIONSGBE could improve kidney damage and alleviate inflammatory response in DN model mice, the mechanism of which may be related to inhibiting the AGEs-RAGE/RhoA/ROCK signaling pathway and regulating macrophage polarization.  
      关键词:diabetic nephropathy;inflammation;macrophage polarization;AGEs-RAGE/RhoA/ROCK signaling pathway   
      23
      |
      4
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374623 false
      发布时间:2024-01-24
    • LIU Xin,LI Qingshan,XIE Yunpeng,ZHANG Shenglin,DONG Yi
      Vol. 35, Issue 2, Pages: 192-197(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.12
      摘要:OBJECTIVETo investigate the effects of anlotinib on the malignant phenotype of glioma cells by regulating the nuclear factor-κB (NF-κB) signaling pathway.METHODSHuman glioma T98G cells were cultured in vitro, and 5-fluorouracil was used as positive control to investigate the effects of different concentrations of anlotinib (5, 10, 20 μmol/L) on the ability of proliferation, adhesion, migration and invasion, the expressions of epithelial-mesenchymal transition (EMT) related proteins [E-cadherin, N-cadherin, vimentin and fibronectin (FN)]. NF-κB signaling pathway inhibitor (BAY 11-7082) and activator (prostratin) were additionally used to verify the possible mechanism of the above effects of anlotinib.RESULTSAnlotinib with 5, 10, 20 μmol/L could significantly decrease the activity of cell proliferation (except for 5 μmol/L anlotinib group), migration rate, and the number of adherent cells and invasive cells, could significantly up-regulate the expression of E-cadherin protein while down-regulate the expressions of N-cadherin, vimentin and FN protein (P<0.05); the effect of 20 μmol/L anlotinib was similar to that of positive control (P>0.05). Compared with 10 μmol/L anlotinib, pathway inhibitor could significantly decrease the ability of proliferation, adhesion, migration and invasion, and the expressions of N-cadherin, vimentin, FN and phosphorylated NF-κB p65 protein, while could significantly up-regulate the expression of E-cadherin protein (P<0.05); above indexes were reversed significantly by pathway activator (P<0.05).CONCLUSIONSAnlotinib may inhibit the proliferation, adhesion, migration and invasion of human glioma T98G cells, which may be associated with the inhibition of the NF-κB signaling pathway, thus inhibiting cell EMT-like processes.  
      关键词:anlotinib;nuclear factor-κB signaling pathway;epithelial-mesenchymal transition   
      14
      |
      15
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374620 false
      发布时间:2024-01-24
    • XIONG Wei,PENG Bin,GAO Zhi
      Vol. 35, Issue 2, Pages: 198-203(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.13
      摘要:OBJECTIVETo investigate the effects of echinacoside (ECH) on renal injury in uremia (URE) rats and its mechanism.METHODSURE model of the rat was established by 5/6 nephrectomy. Successfully modeled rats were grouped into uremia group (URE group), ECH low-dose [10 mg/(kg·d)] group, ECH medium-dose [20 mg/(kg·d)] group, ECH high-dose [40 mg/(kg·d)] group, ECH high-dose+anisomycin [p38 mitogen-activated protein kinase (p38 MAPK) pathway activator] group [ECH-H+Ani group, 40 mg/(kg·d) ECH +2 mg/(kg·d) anisomycin], with a sham operation group, 12 mice in each group. Each drug group was given corresponding ECH intragastrically, while ECH-H+Ani group was further injected with anisomycin via the tail vein, once a day, for 8 consecutive weeks. The serum levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, blood urea nitrogen (BUN), β2-microglobulin (β2-MG), serum creatinine (Scr), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), cystatin C (Cys-C) and 24 h urine protein (24 h UP) as well as the levels of malondialdehyde (MDA) and superoxide dismutase (SOD) activity in renal tissue were all detected; pathological changes of renal tissue were observed; the rate of positive expression of α-smooth muscle protein (α-SMA) and E-cadherin, and the phosphorylation of p38 MAPK and nuclear factor-κB (NF-κB) p65 were determined in renal tissue of rats.RESULTSCompared with URE group, glomerular swelling, damage and necrosis of renal tubular epithelial cells and inflammatory cell infiltration were relieved significantly in ECH groups. The renal injury score, levels of TNF-α, IL-1β, IL-6, BUN, Scr, β2-MG, 24 h UP, NGAL, KIM-1, Cys-C and MDA, the positive expression rate of α-SMA in renal tissue, the phosphorylation of p38 MAPK and NF-κB p65 were decreased in dose-dependent manner, while SOD activity and the positive expression rate of E-cadherin were obviously increased in dose-dependent manner (P<0.05). Anisomycin significantly attenuated the improvement effect of high-dose ECH on renal injury in URE rats (P<0.05).CONCLUSIONSECH may inhibit inflammation and oxidative stress, enhance renal function, and improve renal injury in uremic rats by inhibiting the activation of p38 MAPK/NF-κB signaling pathway.  
      关键词:uremia;renal injury;p38 mitogen-activated protein kinase/nuclear factor-κB signaling pathway   
      7
      |
      1
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375141 false
      发布时间:2024-01-24
    • WU Yanan,WU Fang,HOU Yanhong
      Vol. 35, Issue 2, Pages: 204-209(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.14
      摘要:OBJECTIVETo evaluate the cost-effectiveness of trastuzumab deruxtecan(T-DXd) versus trastuzumab emtansine (T-DM1) in the second-line treatment of HER2-positive metastatic breast cancer, and to provide a basis for the selection of clinical medication regimen and medical and health decisions.METHODSBased on the clinical trial DESTINY-Breast03, a partitioned survival model was constructed, with a cycle of 3 weeks as the simulation of patients’ lifetime. The incremental cost-effectiveness ratio (ICER) was calculated by using quality-adjusted life years (QALY) as output indicators, and sensitivity analysis was used to verify the robustness of the basic analysis results; the cost-effectiveness of the second-line treatment for HER2-positive metastatic breast cancer was compared between T-DXd and T-DM1.RESULTSUnder the premise of taking 3 times China’s per capita gross domestic product (GDP) in 2022 as the willingness-to-pay threshold (257 094 yuan/QALY), the T-DXd group also needed to pay more cost compared with T-DM1 group while obtaining incremental utility (0.69 QALYs), and the ICER value was 1 850 478.40 yuan/QALY. The results of univariate sensitivity analysis showed that progression-free survival state utility value, T-DXd price, cost discount rate were factors that had a great influence on ICER value, but these parameters could not flip the basic analysis results within a reasonable range. In the probability sensitivity analysis, when the threshold of willingness-to-pay rose to 1 500 400 yuan/QALY, the probability of economic activity was 50% in the T-DXd regimen. The results of the scenario analysis also verified the robustness of the original research results.CONCLUSIONSUnder the premise of 3 times China’s per capita GDP as the WTP threshold, compared with T-DM1, T-DXd is not cost-effective in the second-line treatment of HER2-positive metastatic breast cancer.  
      关键词:trastuzumab emtansine;HER2-positive metastatic breast cancer;partitioned survival model;cost-utility analysis   
      31
      |
      4
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375010 false
      发布时间:2024-01-24
    • CHEN Yaqing,XU Mengdan,GU Hangye,WU Junlin,CHEN Yong
      Vol. 35, Issue 2, Pages: 210-213(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.15
      摘要:OBJECTIVETo mine the adverse drug event (ADE) signals of selinexor, and to provide reference for its clinical safety medication.METHODSADE data for selinexor reported from July 3rd, 2019 to March 31st, 2023 were collected from the FDA adverse event reporting system (FAERS). Data mining was performed by using the reporting odds ratio (ROR) and proportional reporting ratio (PRR) methods, and categorization statistics were performed by using the system organ class (SOC) and preferred term (PT) from drug ADE terminology set in the MedDRA (version 26.0).RESULTSA total of 3 084 ADE reports were obtained for selinexor, with a total of 134 ADE-positive signals. Among the reported genders, there were 127 males and 124 females, with a predominant age of ≥65 years old (4.12%); the United States had the highest number of reports (96.53%), with consumers being the main reporters (77.27%); severe ADR was mainly characterized by hospitalization/prolonged hospitalization (26.26%), followed by death (17.15%). The top 3 ADE in the list of frequency were nausea (1 162 times), fatigue (790 times) and anorexia (610 times), all of which were mentioned in the selinexor’s instructions. The top 3 signals in the list of strength were device-associated bacteremia (ROR=115.07, PRR=114.94), blepharospasm dysfunction (ROR=106.70, PRR=106.54), and salmonella sepsis (ROR=99.90, PRR=99.81), all of which were not mentioned in the selinexor’s instructions.CONCLUSIONSIn addition to the ADE of nausea mentioned in the instruction manual, attention should also paid to device-associated bacteremia, blepharospasm dysfunction, salmonella sepsis, and other ADE not mentioned in the instruction manual when using selinexor in clinical practice; weekly rechecking of the patient’s blood routine should be done to monitor the patient’s blood indexes, symptoms of infection, and so on, to ensure that the safety of drug use.  
      关键词:adverse drug event;signal mining;FDA adverse event reporting system   
      29
      |
      6
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374624 false
      发布时间:2024-01-24
    • YANG Wanying,ZHOU Xiangming,MIAO Yuanyuan,ZHAO Yunhui,WANG Lu,KE Tingyu,BAN Lili
      Vol. 35, Issue 2, Pages: 214-218(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.16
      摘要:OBJECTIVETo investigate the effects of renally inappropriate medication (RIM) on the frailty of elderly patients with diabetes.METHODSThe data of elderly patients with diabetes mellitus admitted to a third-grade class A hospital in Yunnan province from January to December 2022 were collected, and Beers criteria (2019 edition) and Chinese version of FRAIL scale were used to evaluate RIM and the frailty of the patients; the patients were divided into the trial group (with RIM) and the control group (without RIM) according to whether there was RIM. The propensity score matching was used to balance confounding factors between two groups, and the influence of RIM on the frailty of elderly diabetic patients was analyzed by the Logistic regression model.RESULTSAmong the 367 patients, 80 patients (21.80%) had RIM, the drugs involved RIM were spironolactone (82.56%), rivaroxaban (13.95%) and gabapentin (3.49%). After reaching the balance between groups using the propensity score matching method, the incidence of frailty was 77.94% in trial group and 27.94% in control group (P<0.001); the difference was not statistically significant in other confounding factors between the two groups (P>0.05). Results of Logistic regression analysis showed that the risk of frailty in the experimental group was 3.118 times that of the control group (odds ratio was 3.118,95% confidence interval was 1.758-5.530, P<0.001).CONCLUSIONSRIM is a risk factor for the frailty of elderly patients with diabetes, which can be considered as an indicator for early identification and screening of the frailty of elderly diabetes patients.  
      关键词:frailty;elderly;diabetes;propensity score matching   
      23
      |
      6
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374784 false
      发布时间:2024-01-24
    • WANG Pei,WEI Meng,TAO Yingying,ZHAO Yulei,WANG Jing,ZHOU Qiang
      Vol. 35, Issue 2, Pages: 219-225(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.17
      摘要:OBJECTIVETo evaluate the clinical efficacy and safety of aspirin versus other anticoagulants in the prevention of thromboembolism after orthopedic surgery.METHODSRetrieved from PubMed, Embase, the Cochrane Library, CNKI, Wanfang data and VIP, randomized controlled trials (RCTs) and cohort studies about aspirin (trial group) versus other anticoagulants (control group) were collected during the inception and June 1st, 2023. After literature screening, data extraction and quality evaluation, the meta-analysis was conducted by using RevMan 5.4 software.RESULTSA total of 22 studies were included, involving 9 RCTs and 13 cohort studies. RCT results showed that the incidences of deep vein thrombosis (DVT) [RR=1.81, 95%CI(1.36, 2.40), P<0.000 1] and postoperative pulmonary embolism (PE) [RR=1.55, 95%CI(1.01, 2.40), P=0.05] in trial group were significantly higher than control group. There was no statistically significant difference in the incidences of postoperative massive bleeding, postoperative surgical site infection, all-cause death, or any bleeding after surgery between 2 groups. In the cohort study, the incidence of any bleeding in trial group was significantly lower than control group [RR=0.71, 95%CI (0.64, 0.79), P<0.000 1], while the differences in other indicators were not statistically significant (P>0.05). The results of subgroup analysis based on different anticoagulants showed that in RCT, the incidences of DVT and PE after surgery in patients using low-molecular-weight heparin (LMWH) were significantly lower than using aspirin (P<0.05); in the cohort study, the incidences of DVT and PE after surgery were significantly lower in patients using direct oral anticoagulants (DOAC) than using aspirin (P<0.05). There was no statistically significant difference in the incidence of major bleeding between patients using aspirin and using DOAC and LWMH (P>0.05) in both RCT and cohort study.CONCLUSIONSAspirin is equally safe as other anticoagulants for the prevention of thromboembolism after orthopedic surgery, but its efficacy may not be as good as other anticoagulants. After orthopedic surgery, other anticoagulants should be preferred to prevent venous thromboembolism, and aspirin should be carefully considered.  
      关键词:aspirin;anticoagulants;thromboembolism;efficacy;safety;meta-analysis   
      22
      |
      7
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374750 false
      发布时间:2024-01-24
    • ZHANG Xiaodan,WANG Ruiqin,LIU Lu,REN Meijuan,YAN Meixing
      Vol. 35, Issue 2, Pages: 226-230(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.18
      摘要:OBJECTIVETo compare the efficacy and safety of Saccharomyces boulardii and Bifidobacterium triple live bacteria in the treatment of pediatric diarrhea.METHODSRetrieved from PubMed, Embase, the Cochrane Library, CBM, Wanfang data, CNKI and VIP, randomized controlled trials (RCTs) about S. boulardii (S. boulardii group) versus Bifidobacterium triple liver bacteria (Bifidobacterium group) were collected. After screening the literature, extracting data and evaluating the quality, meta-analysis was performed by using RevMan 5.3 software.RESULTSA total of 9 RCTs were included, involving 898 patients. Results of meta-analysis showed there was no statistical significance in total response rate [OR=1.69, 95%CI (0.93, 3.09), P=0.09], duration of diarrhea [MD=-1.39, 95%CI (-3.35, 0.57), P=0.16], the time of abdominal pain disappearance [MD=0.09, 95%CI(-0.87, 1.05),P=0.86] or the incidence of adverse reactions [OR=0.65, 95%CI (0.05, 8.03), P=0.74]. The number of stools in S. boulardii group was significantly less than Bifidobacterium group [MD=-0.91, 95%CI (-1.80, -0.02), P=0.04]. The results of subgroup analysis showed that the duration of diarrhea in children with antibiotic-associated diarrhea in S. boulardii group was significantly shorter than Bifidobacterium group (P<0.05).CONCLUSIONSThe efficacy and safety of S. boulardii are similar to those of Bifidobacterium in the treatment of diarrhea, but S. boulardii is better than Bifidobacterium in terms of stool number, the duration of diarrhea in children with antibiotic-associated diarrhea.  
      关键词:Bifidobacterium triple live bacteria;pediatric diarrhea;efficacy;safety;meta-analysis   
      17
      |
      8
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374735 false
      发布时间:2024-01-24
    • LI Xixi,LU Hao,WU Mingfen,ZHAO Zhigang
      Vol. 35, Issue 2, Pages: 231-236(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.19
      摘要:OBJECTIVETo explore the hotspots of aging adaptation of drug package inserts, and to provide evidence for the development of aging adaptation of drug package inserts in China.METHODSThe relevant English literature on drug package inserts for the elderly published from 2012 to 2022 was retrieved from Web of Science Core Collection; bibliometric analysis was performed by using VOSviewer and CiteSpace software, to explore research hotspots in this field, and summarize obstacles and solutions for the development of this field.RESULTS&CONCLUSIONSThis study collected a total of 335 literature related to the aging adaption of drug package inserts, from 819 research institutions in 51 countries (regions), involving 2 174 authors. The research development of drug package insert adaptation for the elderly has slowed down in the past decade, and developed countries such as the United States and Japan dominate this field. Authors such as Wolf from Northwestern University in the United States, have the largest number of publications(12 literature). The research focuses in this field include the risk management of medication for the elderly, the updating of medication information for the elderly in drug package inserts, and the understanding and compliance of the elderly with drug package inserts and their influencing factors. The solutions to related obstacles in the development of aging adaption in drug package inserts include improving the visibility and readability of drug package inserts, filling in the information on elderly medication in drug package inserts, and so on. China can learn from the experiences and methods of other countries, conduct investigations into the influencing factors of elderly package inserts and pharmacokinetic studies based on the characteristics of the Chinese population, and improve the safety of medication for elderly patients in multiple dimensions.  
      关键词:aging adaption;bibliometrics;medication safety;the elderly   
      32
      |
      11
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374874 false
      发布时间:2024-01-24
    • HE Linfeng,YANG Yaya,LIN Yunzhu,YANG Chunsong,ZHANG Lingli
      Vol. 35, Issue 2, Pages: 237-241(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.20
      摘要:OBJECTIVETo reduce dispensing errors in pharmacy intravenous admixture service (PIVAS) of children’s hospitals.METHODSThe risk of dispensing procedures in our PIVAS was identified by applying failure mode and effect analysis (FMEA) model. Potential failure modes that might lead to dispensing errors in each link were determined, and failure causes were analyzed. The severity, incidence and detection degree of potential failure modes were quantitatively scored, and their risk priority number (RPN) was calculated to screen failure modes that needed to be improved in priority; the corresponding improvement measures were developed by 6S management method from six aspects, namely, finishing (seiri), rectifying (seiton), sweeping (seiso), sanitation (seiketsu), literacy (shitsuke) and safety. The effect of intervention before and after rectification was evaluated.RESULTSBased on the RPN, 32 potential failure modes were selected, of which a total of 18 critical failure modes that needed to be improved in priority. After implementing corresponding measures according to 6S management method, the RPN of 18 critical failure modes decreased. The total RPN decreased from 497 to 142 with a decrease rate of 71.43%. The error rates of 15 critical failure modes were significantly lower than before implementation (P<0.05).CONCLUSIONSApplying FMEA model and 6S management method to the risk control of all aspects of PIVAS workflow can effectively reduce the risk of PIVAS dispensing errors and ensure the safety of children’s intravenous medication.  
      关键词:dispensing errors;risk evaluation;failure mode and effect analysis;6S management   
      13
      |
      5
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375075 false
      发布时间:2024-01-24
    • LAI Zongqiang,LI Jun,SHANG Yongguang
      Vol. 35, Issue 2, Pages: 242-246(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.21
      摘要:OBJECTIVETo provide ideas and reference for the anti-infection treatment and pharmaceutical care for severe pneumonia caused by Chlamydia psittaci.METHODSClinical pharmacists participated in the whole process of the treatment for a patient with C. psittaci-induced severe pneumonia. According to the patient’s medical history, clinical symptoms and test results, clinical pharmacists assisted the physician to dynamically adjust the anti-infective scheme; for C. psittaci infection, the patient was treated with tigecycline combined with azithromycin successively, and other infection therapy plans were dynamically adjusted according to the results of pathogen examination. During the treatment, the patient suffered from suspicious adverse drug reactions such as prolonged QTc interval, elevated lipase and amylase; the clinical pharmacists conducted pharmaceutical care and put forward reasonable suggestions.RESULTSThe physician adopted the pharmacists’ suggestion, and the patient was discharged after treatment.CONCLUSIONSFor the treatment of severe pneumonia caused by C. psittaci, the characteristics of patients, drugs and pathogens should be taken into account to develop individualized anti-infective treatment. Tetracyclines and macrolides have a definite effect on C. psittaci infection, but attention should be paid to the possible ADR caused by drugs in clinical application.  
      关键词:severe pneumonia;tigecycline;azithromycin;clinical pharmacist;pharmaceutical care   
      29
      |
      13
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48375143 false
      发布时间:2024-01-24
    • DU Zhongying,ZHENG Zhaohong,WEI Liang,HOU Qiuyu
      Vol. 35, Issue 2, Pages: 247-250(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.22
      摘要:OBJECTIVETo provide reference for safe drug use in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).METHODSClinical pharmacists participated in the diagnosis and treatment of a patient with ALK-positive NSCLC who developed bilateral pleural effusion and hemolytic anemia after taking alectinib; regarding symptoms such as pleural effusion and hemolytic anemia in the patient, clinical pharmacists investigated the patient’s history of medication and disease, as well as potential drug interaction; to consider the correlation between the patient’s use of alectinib and the duration of pleural effusion and hemolytic anemia, clinical pharmacists suggested that clinical doctors discontinued alectinib and used reduced dose treatment after the pleural effusion improved, but the patient suffered from bilateral pleural effusion and hemolytic anemia again; after evaluating the correlation between alectinib and bilateral pleural effusion and hemolytic anemia using the Naranjo’s assessment scale, clinical pharmacists recommend permanent discontinuation of alectinib and jointly recommend replacement with ensartinib with clinical physicians.RESULTSPhysicians adopted the suggestions of clinical pharmacists. The pleural effusion subsequently regressed and hemolytic anemia improved after replacing the drug. The correlation between alectinib and bilateral pleural effusion and hemolytic anemia was confirmed.CONCLUSIONSClinical pharmacists participate in pharmaceutical monitoring of ALK-positive NSCLC patients, assist clinical doctors in developing personalized medication recommendations, and ensure the safety of patient medication.  
      关键词:pleural effusion;hemolytic anemia;pharmaceutical care   
      14
      |
      4
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374752 false
      发布时间:2024-01-24
    • GAO Chang,NI Bin,CHEN Fanghui,GUO Chunyu,WEI Guilin
      Vol. 35, Issue 2, Pages: 251-256(2024) DOI: 10.6039/j.issn.1001-0408.2024.02.23
      摘要:Levetiracetam (LEV) is the second generation of broad-spectrum anti-epileptic drug. LEV has the advantages of rapid absorption, short half-life, precise efficacy, good tolerance and few drug interactions. In order to improve the clinical efficacy of LEV, and reduce the occurrence of adverse reactions, children, pregnant women, the elderly, and patients with renal insufficiency should receive therapeutic drug monitoring (TDM). Clinically, the samples are usually plasma or serum, and the TDM methods are mostly immunoassay or chromatography. There is currently no consensus on the effective concentration range of LEV, and the correlation between plasma concentration and adverse reactions is also unclear. The main factors affecting LEV plasma concentration include age, pregnancy, and patient compliance. How to interpret TDM results and adjust dosage based on the results will be the focus of future work.  
      关键词:therapeutic drug monitoring;rational drug use;plasma concentration   
      34
      |
      4
      |
      0
      <HTML>
      <L-PDF><WORD><Meta-XML>
      <引用本文> <批量引用> 48374937 false
      发布时间:2024-01-24
    0